Sequential Immunotherapy

Sequential Immunotherapy is a treatment strategy in immuno-oncology that belongs to the class of immunotherapy sequencing approaches, distinguished by the administration of immunotherapeutic agents in a non-overlapping, predetermined order to optimize therapeutic efficacy and immune system engagement.

68

Publications

3.7K

Citations

709

Authors

357

Institutions

Publications per year

2017–2026

39

Authors

709

  1. CL
    Célèste Lebbé

    Hôpital Saint-Louis, France

    4 publications · 339 citations

    4

    h-index

  2. PA
    Paolo A. Ascierto

    Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy

    4 publications · 342 citations

    4

    h-index

  3. AM
    Antonio Maria Grimaldi

    Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy

    4 publications · 342 citations

    4

    h-index

  4. FS
    F. Stephen Hodi

    Dana-Farber Cancer Institute, United States

    4 publications · 963 citations

    4

    h-index

  5. DF
    David F. McDermott

    Beth Israel Deaconess Medical Center, United States

    3 publications · 337 citations

    3

    h-index

1–5 of 709

Venues

  1. Journal of Clinical Oncology

    12 publications · 665 citations

    11

    h-index

  2. European Journal of Cancer

    3 publications · 79 citations

    3

    h-index

  3. Blood

    3 publications · 80 citations

    3

    h-index

  4. OncoImmunology

    3 publications · 74 citations

    3

    h-index

  5. Cancer

    2 publications · 317 citations

    2

    h-index

1–5